| Name | Title | Contact Details |
|---|
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.
Employment Services Inc is a Searcy, AR-based company in the Business Services sector.
Zylon Polymers is a Spring Valley, NY-based company in the Business Services sector.
Since founded on May 5th of 2011, Southern Rock Restaurants, LLC have purchased and operate 90 McAlisters Deli restaurants in Tennessee, Mississippi, Missouri, Kentucky, Ohio, Illinois and Indiana.
Metroservices Inc is a Carlsbad, CA-based company in the Business Services sector.